The mission of ReNetX Bio is to provide first-in-class therapeutics to treat injury/damage to the central nervous system in conditions such as spinal cord injury, stroke, and glaucoma.

The company was founded based on technology from Dr. Stephen Strittmatter’s work at Yale University.

more